PIA
ANIP icon

Piedmont Investment Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Piedmont Investment Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,096
Closed -$140K – 1102
2018
Q2 		$140K Buy
+2,096
New +$131K 0.01% 996

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Piedmont Investment Advisors's ANIP Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of ANI Pharmaceuticals (ANIP) in Q3 2018, closing a stake of 2,096 shares — an estimated $140K sold.

Piedmont Investment Advisors first reported a position in ANIP in Q2 2018 and held it in 1 quarter. The position peaked at $140K in Q2 2018. 173 funds tracked by Wall St. Rank hold ANIP as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining ANI Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 2,096 ANI Pharmaceuticals shares in Q3 2018, an estimated $140K.
  • Piedmont Investment Advisors first reported a position in ANI Pharmaceuticals in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's ANI Pharmaceuticals position peaked at $140K in Q2 2018.
  • 173 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.